• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EClinicalMedicine . Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical eval

tetano

Editor, Senior Moderator
EClinicalMedicine


. 2021 Aug 28;40:101101.
doi: 10.1016/j.eclinm.2021.101101. eCollection 2021 Oct.
Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa


Marycelin Mandu Baba[SUP] 1 [/SUP], Molalegne Bitew[SUP] 2 [/SUP], Joseph Fokam[SUP] 3 4 [/SUP], Eric Agola Lelo[SUP] 5 [/SUP], Ahmed Ahidjo[SUP] 1 [/SUP], Kominist Asmamaw[SUP] 2 [/SUP], Grace Angong Beloumou[SUP] 3 [/SUP], Wallace Dimbuson Bulimo[SUP] 5 [/SUP], Emanuele Buratti[SUP] 6 [/SUP], Collins Chenwi[SUP] 3 [/SUP], Hailu Dadi[SUP] 2 [/SUP], Pierlanfranco D'Agaro[SUP] 7 8 [/SUP], Laura De Conti[SUP] 6 [/SUP], Nadine Fainguem[SUP] 3 [/SUP], Galadima Gadzama[SUP] 1 [/SUP], Paolo Maiuri[SUP] 9 [/SUP], Janet Majanja[SUP] 5 [/SUP], Wadegu Meshack[SUP] 5 [/SUP], Alexis Ndjolo[SUP] 3 [/SUP], Celine Nkenfou[SUP] 3 [/SUP], Bamidele Soji Oderinde[SUP] 1 [/SUP], Silvanos Mukunzi Opanda[SUP] 5 [/SUP], Ludovica Segat[SUP] 7 [/SUP], Cristiana Stuani[SUP] 6 [/SUP], Samwel L Symekher[SUP] 5 [/SUP], Desire Takou[SUP] 3 [/SUP], Kassahun Tesfaye[SUP] 2 [/SUP], Gianluca Triolo[SUP] 6 [/SUP], Keyru Tuki[SUP] 2 [/SUP], Serena Zacchigna[SUP] 6 [/SUP], Alessandro Marcello[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Management and control of the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus SARS-CoV-2 is critically dependent on quick and reliable identification of the virus in clinical specimens. Detection of viral RNA by a colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) is a simple, reliable and cost-effective assay, deployable in resource-limited settings (RLS). Our objective was to evaluate the intrinsic and extrinsic performances of RT-LAMP in RLS.
Methods: This is a multicenter prospective observational study of diagnostic accuracy, conducted from October 2020 to February 2021 in four African Countries: Cameroon, Ethiopia, Kenya and Nigeria; and in Italy. We enroled 1657 individuals who were either COVID-19 suspect cases, or asymptomatic and presented for screening. RNA extracted from pharyngeal swabs was tested in parallel by a colorimetric RT-LAMP and by a standard real time polymerase chain reaction (RT-PCR).
Findings: The sensitivity and specificity of index RT LAMP compared to standard RT-PCR on 1657 prospective specimens from infected individuals was determined. For a subset of 1292 specimens, which underwent exactly the same procedures in different countries, we obtained very high specificity (98%) and positive predictive value (PPV = 99%), while the sensitivity was 87%, with a negative predictive value NPV = 70%, Stratification of RT-PCR data showed superior sensitivity achieved with an RT-PCR cycle threshold (Ct) below 35 (97%), which decreased to 60% above 35.
Interpretation: In this field trial, RT-LAMP appears to be a reliable assay, comparable to RT-PCR, particularly with medium-high viral loads (Ct < 35). Hence, RT-LAMP can be deployed in RLS for timely management and prevention of COVID-19, without compromising the quality of output.
 
Back
Top Bottom